SECTOR GAMMA AS

CIK

1475373

Location

OSLO, Q8

Portfolio Value

Small $460,970,491

Diversification

Diversified

Filing Date

Global Rank

#3,902 / 8,811 ▼ 326

Top Industry

Drug Manufacturers - General 25.8%

Period ended 4 months ago

Filed Aug 12, 2026 · 2mo

26 quarters · since Mar 2020

Regulatory profile

From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.

Holder type

Unknown

Portfolio style

Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.

Style

Diversified active

Top 10 weight 48.4%, 27.0 effective positions, active share 96.5% against the Dow Jones Industrial Average as of 2026-07-31; it meets none of the index-like, systematic-like or concentrated tests

Turnover

Medium turnover

58.9% over the last four quarters (30% to under 100%)

Horizon

Long horizon

Value-weighted holding period 13.6 quarters (12+), a floor since 26.9% of the book was already held when coverage starts

Closest benchmark: the Dow Jones Industrial Average as of 2026-07-31, active share 96.5%; sector active share 90.6% against the combined 13F book's sector weights.

Over time 26 measured quarters

How the bands are measured

Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

40 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026

Top Position

9.1%

−2.8 pts

Top 5

30.6%

−6.1 pts

Top 10

48.4%

−5.7 pts

HHI

370

Diversified−73

Portfolio Trend

26 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$460,970,491	40

Last Quarter's Activity

Export CSV

Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased

19 positions

Ticker	Company	Δ Shares	Shares	Value
AVTR	Avantor, Inc.	+210,685	906,088	$8,970,271
ARDX	Ardelyx, Inc.	+170,713	686,844	$3,502,904
QGEN	Qiagen N.V.	+125,269	287,640	$11,246,724
GEHC	GE HealthCare Technologies Inc.	+81,445	207,863	$13,305,310
MDT	Medtronic plc	+71,755	352,437	$27,571,146
IOVA	Iovance Biotherapeutics, Inc.	+68,466	968,466	$4,028,818
ABT	Abbott Laboratories	+59,912	147,444	$13,379,068
BMRN	Biomarin Pharmaceutical Inc	+55,000	294,918	$16,875,207
DXCM	Dexcom Inc	+46,000	102,122	$6,877,916
IQV	Iqvia Holdings Inc.	+37,714	77,944	$15,060,339
PTCT	Ptc Therapeutics, Inc.	+25,000	100,000	$8,157,000
KURA	Kura Oncology, Inc.	+21,202	433,012	$4,750,141
—		+20,433	114,628	$4,289,379
IONS	Ionis Pharmaceuticals Inc	+20,000	189,468	$15,022,917
CVS	CVS HEALTH Corp	+20,000	155,337	$16,069,612
BDX	Becton Dickinson & Co	+10,553	93,168	$14,099,113
BIO	Bio-Rad Laboratories, Inc.	+9,600	33,350	$9,791,893
LH	Labcorp Holdings Inc.	+7,000	26,019	$7,285,320
ELV	Elevance Health, Inc.	+537	44,499	$17,209,098
No positions match the current search.

Trimmed

Positions the filer reduced

11 positions

Ticker	Company	Δ Shares	Shares	Value
OGN	Organon & Co.	−105,193	270,781	$3,666,374
BMY	Bristol Myers Squibb Co	−101,786	726,115	$41,838,746
BRKR	Bruker Corp	−101,658	152,352	$9,168,543
PFE	Pfizer Inc	−87,170	1,004,215	$24,181,497
SNDX	Syndax Pharmaceuticals Inc	−44,268	241,739	$5,284,414
MRK	Merck & Co., Inc.	−43,332	217,008	$27,885,528
BIIB	Biogen Inc.	−35,933	54,163	$11,702,457
INCY	Incyte Corp	−29,757	170,753	$19,356,560
AMGN	Amgen Inc	−20,874	26,281	$9,516,875
CAH	Cardinal Health Inc	−14,208	40,689	$9,666,078
ZBH	Zimmer Biomet Holdings, Inc.	−13,528	142,307	$12,251,209
No positions match the current search.

New Positions

Positions the filer opened this quarter

6 positions

Ticker	Company	Shares	Value
TMO	Thermo Fisher Scientific Inc.	33,584	$16,837,674
REGN	Regeneron Pharmaceuticals, Inc.	15,780	$9,839,461
BSX	Boston Scientific Corp	121,128	$5,169,743
TVTX	Travere Therapeutics, Inc.	80,000	$4,544,800
CYTK	Cytokinetics Inc	45,000	$3,833,550
NTLA	Intellia Therapeutics, Inc.	185,177	$3,133,194
No positions match the current search.

Sold Out

Positions the filer fully exited

8 positions

Ticker	Company	Shares	Value
UNH	Unitedhealth Group Inc	36,435	$9,858,946
GILD	Gilead Sciences, Inc.	53,247	$7,421,034
LNTH	Lantheus Holdings, Inc.	93,344	$7,080,142
HUM	Humana Inc	19,202	$3,329,434
BBIO	BridgeBio Pharma, Inc.	44,263	$3,286,970
DNLI	Denali Therapeutics Inc.	162,710	$3,124,032
COGT	Cogent Biosciences, Inc.	80,000	$3,079,200
ARWR	Arrowhead Pharmaceuticals, Inc.	30,000	$1,881,000
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

40 tracked positions · $460,970,491 total · filing declares 40 positions · $460,970,513 · as of Jun 30, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	Held (qtrs)	Est. cost/share	% of Portfolio
BMY	Bristol Myers Squibb Co Healthcare	Reduced	726,115	-101,786	$41,838,746	−16.7%	26+	before history	9.08%
MRK	Merck & Co., Inc. Healthcare	Reduced	217,008	-43,332	$27,885,528	−11.0%	5	$82.07	6.05%
MDT	Medtronic plc Healthcare	Added	352,437	+71,755	$27,571,146	+13.4%	25	$88.17	5.98%
PFE	Pfizer Inc Healthcare	Reduced	1,004,215	-87,170	$24,181,497	−21.1%	11	$27.66	5.25%
INCY	Incyte Corp Healthcare	Reduced	170,753	-29,757	$19,356,560	+2.6%	26+	before history	4.20%
ELV	Elevance Health, Inc. Healthcare	Added	44,499	+537	$17,209,098	+33.7%	26+	before history	3.73%
BMRN	Biomarin Pharmaceutical Inc Healthcare	Added	294,918	+55,000	$16,875,207	+24.5%	19	$67.08	3.66%
TMO	Thermo Fisher Scientific Inc. Healthcare	NEW	33,584	NEW	$16,837,674	NEW	1	$480.05	3.65%
CVS	CVS HEALTH Corp Healthcare	Added	155,337	+20,000	$16,069,612	+65.3%	11	$72.48	3.49%
IQV	Iqvia Holdings Inc. Healthcare	Added	77,944	+37,714	$15,060,339	+119.5%	2	$185.07	3.27%
IONS	Ionis Pharmaceuticals Inc Healthcare	Added	189,468	+20,000	$15,022,917	+18.1%	26+	before history	3.26%
BDX	Becton Dickinson & Co Healthcare	Added	93,168	+10,553	$14,099,113	+8.5%	8	$167.71	3.06%
ABT	Abbott Laboratories Healthcare	Added	147,444	+59,912	$13,379,068	+48.9%	2	$104.12	2.90%
GEHC	GE HealthCare Technologies Inc. Healthcare	Added	207,863	+81,445	$13,305,310	+47.9%	13	$72.37	2.89%
ZBH	Zimmer Biomet Holdings, Inc. Healthcare	Reduced	142,307	-13,528	$12,251,209	−13.1%	18	unpriced	2.66%
BIIB	Biogen Inc. Healthcare	Reduced	54,163	-35,933	$11,702,457	−29.2%	26+	before history	2.54%
QGEN	Qiagen N.V. Healthcare	Added	287,640	+125,269	$11,246,724	+73.0%	2	$42.89	2.44%
CNC	Centene Corp Healthcare	Held	162,405	0	$10,424,776	+96.1%	23	$53.34	2.26%
REGN	Regeneron Pharmaceuticals, Inc. Healthcare	NEW	15,780	NEW	$9,839,461	NEW	1	$680.68	2.13%
BIO	Bio-Rad Laboratories, Inc. Healthcare	Added	33,350	+9,600	$9,791,893	+47.9%	11	$291.29	2.12%
CAH	Cardinal Health Inc Healthcare	Reduced	40,689	-14,208	$9,666,078	−16.7%	26+	before history	2.10%
AMGN	Amgen Inc Healthcare	Reduced	26,281	-20,874	$9,516,875	−42.6%	9	$294.01	2.06%
BRKR	Bruker Corp Healthcare	Reduced	152,352	-101,658	$9,168,543	−0.1%	26+	before history	1.99%
AVTR	Avantor, Inc. Healthcare	Added	906,088	+210,685	$8,970,271	+64.5%	5	$12.08	1.95%
PTCT	Ptc Therapeutics, Inc. Healthcare	Added	100,000	+25,000	$8,157,000	+59.6%	7	$56.08	1.77%
LH	Labcorp Holdings Inc. Healthcare	Added	26,019	+7,000	$7,285,320	+43.6%	5	$253.63	1.58%
DXCM	Dexcom Inc Healthcare	Added	102,122	+46,000	$6,877,916	+95.1%	5	$73.23	1.49%
ASND	Ascendis Pharma A/S Healthcare	Held	21,305	0	$5,682,469	+16.6%	6	$172.00	1.23%
EW	Edwards Lifesciences Corp Healthcare	Held	60,402	0	$5,463,964	+13.0%	15	$78.07	1.19%
SNDX	Syndax Pharmaceuticals Inc Healthcare	Reduced	241,739	-44,268	$5,284,414	−20.9%	4	$14.74	1.15%
BSX	Boston Scientific Corp Healthcare	NEW	121,128	NEW	$5,169,743	NEW	1	$54.30	1.12%
KURA	Kura Oncology, Inc. Healthcare	Added	433,012	+21,202	$4,750,141	+41.9%	4	$7.36	1.03%
TVTX	Travere Therapeutics, Inc. Healthcare	NEW	80,000	NEW	$4,544,800	NEW	1	$44.34	0.99%
		Added	114,628	+20,433	$4,289,379	+25.4%	3	$43.21	0.93%
TNDM	Tandem Diabetes Care Inc Healthcare	Held	267,091	0	$4,030,403	−21.3%	6	$24.77	0.87%
IOVA	Iovance Biotherapeutics, Inc. Healthcare	Added	968,466	+68,466	$4,028,818	+27.5%	2	$3.24	0.87%
CYTK	Cytokinetics Inc Healthcare	NEW	45,000	NEW	$3,833,550	NEW	1	$71.80	0.83%
OGN	Organon & Co. Healthcare	Reduced	270,781	-105,193	$3,666,374	+62.8%	4	$9.35	0.80%
ARDX	Ardelyx, Inc. Healthcare	Added	686,844	+170,713	$3,502,904	+13.3%	2	$6.49	0.76%
NTLA	Intellia Therapeutics, Inc. Healthcare	NEW	185,177	NEW	$3,133,194	NEW	1	$14.00	0.68%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.